{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:10:13Z","timestamp":1794035413526,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/s41594-018-0049-1","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:20:18Z","timestamp":1522797618000},"page":"333-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":323,"title":["Structural basis of small-molecule inhibition of human multidrug transporter ABCG2"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8309-4713","authenticated-orcid":false,"given":"Scott M.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Manolaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-1896","authenticated-orcid":false,"given":"Julia","family":"Kowal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Zechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0761-4921","authenticated-orcid":false,"given":"Nicholas M. I.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Bause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Bartholomaeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Buschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-4592","authenticated-orcid":false,"given":"Henning","family":"Stahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8207-2889","authenticated-orcid":false,"given":"Kaspar P.","family":"Locher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"49_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-1-60761-416-6_18","volume":"596","author":"E Crowley","year":"2010","unstructured":"Crowley, E., McDevitt, C. A. & Callaghan, R. Generating inhibitors of P-glycoprotein: where to, now? Methods Mol. Biol. 596, 405\u2013432 (2010).","journal-title":"Methods Mol. Biol."},{"key":"49_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/path.1203","volume":"198","author":"JE Diestra","year":"2002","unstructured":"Diestra, J. E. et al. Frequent expression of the multi-drug resistance-associated protein BCRP\/MXR\/ABCP\/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J. Pathol. 198, 213\u2013219 (2002).","journal-title":"J. Pathol."},{"key":"49_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2005.04.024","volume":"235","author":"PA Fetsch","year":"2006","unstructured":"Fetsch, P. A. et al. Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett. 235, 84\u201392 (2006).","journal-title":"Cancer Lett."},{"key":"49_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","volume":"61","author":"RW Robey","year":"2009","unstructured":"Robey, R. W. et al. ABCG2: a perspective. Adv. Drug Deliv. Rev. 61, 3\u201313 (2009).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"49_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/ph6111347","volume":"6","author":"T Ishikawa","year":"2013","unstructured":"Ishikawa, T., Aw, W. & Kaneko, K. Metabolic interactions of purine derivatives with human ABC transporter ABCG2: genetic testing to assess gout risk. Pharmaceuticals (Basel) 6, 1347\u20131360 (2013).","journal-title":"Pharmaceuticals (Basel)"},{"key":"49_CR6","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2174\/138920111795163931","volume":"12","author":"JP Gillet","year":"2011","unstructured":"Gillet, J. P. & Gottesman, M. M. Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer. Curr. Pharm. Biotechnol. 12, 686\u2013692 (2011).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"49_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M. M., Fojo, T. & Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48\u201358 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"49_CR8","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2174\/1871520616666151120121928","volume":"16","author":"AL Iorio","year":"2016","unstructured":"Iorio, A. L. et al. Blood-brain barrier and breast cancer resistance protein: a limit to the therapy of CNS tumors and neurodegenerative diseases. Anticancer. Agents Med. Chem. 16, 810\u2013815 (2016).","journal-title":"Anticancer. Agents Med. Chem."},{"key":"49_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","volume":"86","author":"B Sarkadi","year":"2006","unstructured":"Sarkadi, B., Homolya, L., Szak\u00e1cs, G. & V\u00e1radi, A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev. 86, 1179\u20131236 (2006).","journal-title":"Physiol. Rev."},{"key":"49_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1042\/bse0500161","volume":"50","author":"FJ Sharom","year":"2011","unstructured":"Sharom, F. J. The P-glycoprotein multidrug transporter. Essays Biochem. 50, 161\u2013178 (2011).","journal-title":"Essays Biochem."},{"key":"49_CR11","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1124\/dmd.113.053140","volume":"41","author":"J Bakhsheshian","year":"2013","unstructured":"Bakhsheshian, J. et al. Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab. Dispos. 41, 1805\u20131812 (2013).","journal-title":"Drug Metab. Dispos."},{"key":"49_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1124\/mol.64.3.610","volume":"64","author":"Y Imai","year":"2003","unstructured":"Imai, Y. et al. Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol. Pharmacol. 64, 610\u2013618 (2003).","journal-title":"Mol. Pharmacol."},{"key":"49_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","volume":"17","author":"Q Mao","year":"2015","unstructured":"Mao, Q. & Unadkat, J. D. Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport\u2013an update. AAPS J. 17, 65\u201382 (2015).","journal-title":"AAPS J."},{"key":"49_CR14","first-page":"1","volume":"3","author":"W Mo","year":"2012","unstructured":"Mo, W. & Zhang, J. T. Human ABCG2: structure, function, and its role in multidrug resistance. Int. J. Biochem. Mol. Biol. 3, 1\u201327 (2012).","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"49_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addr.2008.08.007","volume":"61","author":"ML Vlaming","year":"2009","unstructured":"Vlaming, M. L., Lagas, J. S. & Schinkel, A. H. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv. Drug Deliv. Rev. 61, 14\u201325 (2009).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"49_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4161\/cbt.1.4.20","volume":"1","author":"JD Allen","year":"2002","unstructured":"Allen, J. D. et al. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol. Cancer Ther. 1, 417\u2013425 (2002).","journal-title":"Mol. Cancer Ther."},{"key":"49_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","volume":"152","author":"ML Holland","year":"2007","unstructured":"Holland, M. L., Lau, D. T., Allen, J. D. & Arnold, J. C. The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids. Br. J. Pharmacol. 152, 815\u2013824 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"49_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1021\/cn100078a","volume":"2","author":"P Kannan","year":"2011","unstructured":"Kannan, P. et al. The \u201cspecific\u201d P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP\/ABCG2). ACS Chem. Neurosci. 2, 82\u201389 (2011).","journal-title":"ACS Chem. Neurosci."},{"key":"49_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.phrs.2017.02.024","volume":"119","author":"BG Peterson","year":"2017","unstructured":"Peterson, B. G., Tan, K. W., Osa-Andrews, B. & Iram, S. H. High-content screening of clinically tested anticancer drugs identifies novel inhibitors of human MRP1 (ABCC1). Pharmacol. Res. 119, 313\u2013326 (2017).","journal-title":"Pharmacol. Res."},{"key":"49_CR20","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1016\/j.bmcl.2011.04.094","volume":"21","author":"CO Puentes","year":"2011","unstructured":"Puentes, C. O. et al. Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2). Bioorg. Med. Chem. Lett. 21, 3654\u20133657 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"49_CR21","first-page":"5850","volume":"58","author":"SK Rabindran","year":"1998","unstructured":"Rabindran, S. K. et al. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res. 58, 5850\u20135858 (1998).","journal-title":"Cancer Res"},{"key":"49_CR22","first-page":"47","volume":"60","author":"SK Rabindran","year":"2000","unstructured":"Rabindran, S. K., Ross, D. D., Doyle, L. A., Yang, W. & Greenberger, L. M. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res. 60, 47\u201350 (2000).","journal-title":"Cancer Res."},{"key":"49_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1124\/jpet.115.225482","volume":"354","author":"LD Weidner","year":"2015","unstructured":"Weidner, L. D. et al. The inhibitor Ko143 is not specific for ABCG2. J. Pharmacol. Exp. Ther. 354, 384\u2013393 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"49_CR24","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/cmdc.201300319","volume":"8","author":"S Bauer","year":"2013","unstructured":"Bauer, S. et al. Quinoline carboxamide-type ABCG2 modulators: indole and quinoline moieties as anilide replacements. ChemMedChem 8, 1773\u20131778 (2013).","journal-title":"ChemMedChem"},{"key":"49_CR25","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1021\/acs.jmedchem.5b00188","volume":"58","author":"SC K\u00f6hler","year":"2015","unstructured":"K\u00f6hler, S. C. & Wiese, M. HM30181 derivatives as novel potent and selective inhibitors of the breast cancer resistance protein (BCRP\/ABCG2). J. Med. Chem. 58, 3910\u20133921 (2015).","journal-title":"J. Med. Chem."},{"key":"49_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/ml4000832","volume":"4","author":"C Ochoa-Puentes","year":"2013","unstructured":"Ochoa-Puentes, C. et al. Benzanilide-biphenyl replacement: a bioisosteric approach to quinoline carboxamide-type ABCG2 modulators. ACS Med. Chem. Lett. 4, 393\u2013396 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"49_CR27","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/cmdc.201000216","volume":"5","author":"A Pick","year":"2010","unstructured":"Pick, A., Klinkhammer, W. & Wiese, M. Specific inhibitors of the breast cancer resistance protein (BCRP). ChemMedChem 5, 1498\u20131505 (2010).","journal-title":"ChemMedChem"},{"key":"49_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0960-894X(99)00030-X","volume":"9","author":"M Roe","year":"1999","unstructured":"Roe, M. et al. Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorg. Med. Chem. Lett. 9, 595\u2013600 (1999).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"49_CR29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature22345","volume":"546","author":"NMI Taylor","year":"2017","unstructured":"Taylor, N. M. I. et al. Structure of the human multidrug transporter ABCG2. Nature 546, 504\u2013509 (2017).","journal-title":"Nature"},{"key":"49_CR30","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150150","volume":"35","author":"AJ Haider","year":"2015","unstructured":"Haider, A. J. et al. Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences. Biosci. Rep. 35, e00241 (2015).","journal-title":"Biosci. Rep."},{"key":"49_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164426","volume":"11","author":"L L\u00e1szl\u00f3","year":"2016","unstructured":"L\u00e1szl\u00f3, L., Sarkadi, B. & Heged\u0171s, T. Jump into a new fold-A homology based model for the ABCG2\/BCRP multidrug transporter. PLoS One 11, e0164426 (2016).","journal-title":"PLoS One"},{"key":"49_CR32","doi-asserted-by":"publisher","first-page":"C1100","DOI":"10.1152\/ajpcell.00160.2010","volume":"299","author":"Z Ni","year":"2010","unstructured":"Ni, Z., Bikadi, Z., Cai, X., Rosenberg, M. F. & Mao, Q. Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP\/ABCG2): identification of polar residues important for drug transport. Am. J. Physiol. Cell Physiol. 299, C1100\u2013C1109 (2010).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"49_CR33","doi-asserted-by":"publisher","first-page":"8057","DOI":"10.1021\/bi200573t","volume":"50","author":"Z Ni","year":"2011","unstructured":"Ni, Z. et al. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP\/ABCG2) that are important for transport activity and substrate specificity. Biochemistry 50, 8057\u20138066 (2011).","journal-title":"Biochemistry"},{"key":"49_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11794-w","volume":"7","author":"N Khunweeraphong","year":"2017","unstructured":"Khunweeraphong, N., Stockner, T. & Kuchler, K. The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion. Sci. Rep. 7, 13767 (2017).","journal-title":"Sci. Rep."},{"key":"49_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0960-894X(00)00588-6","volume":"11","author":"A Loevezijn van","year":"2001","unstructured":"van Loevezijn, A., Allen, J. D., Schinkel, A. H. & Koomen, G. J. Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines. Bioorg. Med. Chem. Lett. 11, 29\u201332 (2001).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"49_CR36","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm0901-1028","volume":"7","author":"S Zhou","year":"2001","unstructured":"Zhou, S. et al. The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028\u20131034 (2001).","journal-title":"Nat. Med."},{"key":"49_CR37","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1126\/science.1168750","volume":"323","author":"SG Aller","year":"2009","unstructured":"Aller, S. G. et al. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323, 1718\u20131722 (2009).","journal-title":"Science"},{"key":"49_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.cell.2017.01.041","volume":"168","author":"ZL Johnson","year":"2017","unstructured":"Johnson, Z. L. & Chen, J. Structural basis of substrate recognition by the multidrug resistance protein MRP1. Cell 168, 1075\u20131085.e9 (2017).","journal-title":"Cell"},{"key":"49_CR39","unstructured":"Gergely, S. et al. in Drug Resistance in Cancer Cells (eds Siddik, Z. & Mehta, K.) 1\u201320 (Springer, New York, 2009)."},{"key":"49_CR40","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1021\/jm8013822","volume":"52","author":"M K\u00fchnle","year":"2009","unstructured":"K\u00fchnle, M. et al. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar. J. Med. Chem. 52, 1190\u20131197 (2009).","journal-title":"J. Med. Chem."},{"key":"49_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1124\/jpet.107.122994","volume":"323","author":"CH Storch","year":"2007","unstructured":"Storch, C. H., Ehehalt, R., Haefeli, W. E. & Weiss, J. Localization of the human breast cancer resistance protein (BCRP\/ABCG2) in lipid rafts\/caveolae and modulation of its activity by cholesterol in vitro. J. Pharmacol. Exp. Ther. 323, 257\u2013264 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"49_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.placenta.2017.04.006","volume":"55","author":"JT Szilagyi","year":"2017","unstructured":"Szilagyi, J. T., Vetrano, A. M., Laskin, J. D. & Aleksunes, L. M. Localization of the placental BCRP\/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity. Placenta 55, 29\u201336 (2017).","journal-title":"Placenta"},{"key":"49_CR43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature17666","volume":"533","author":"JY Lee","year":"2016","unstructured":"Lee, J. Y. et al. Crystal structure of the human sterol transporter ABCG5\/ABCG8. Nature 533, 561\u2013564 (2016).","journal-title":"Nature"},{"key":"49_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1124\/dmd.113.055731","volume":"42","author":"Aacute Telbisz","year":"2014","unstructured":"Telbisz, \u00c1., Heged\u00fcs, C., V\u00e1radi, A., Sarkadi, B. & \u00d6zvegy-Laczka, C. Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites. Drug Metab. Dispos. 42, 575\u2013585 (2014).","journal-title":"Drug Metab. Dispos."},{"key":"49_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/mol.108.038299","volume":"73","author":"S Velamakanni","year":"2008","unstructured":"Velamakanni, S., Janvilisri, T., Shahi, S. & van Veen, H. W. A functional steroid-binding element in an ATP-binding cassette multidrug transporter. Mol. Pharmacol. 73, 12\u201317 (2008).","journal-title":"Mol. Pharmacol."},{"key":"49_CR46","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00018-015-2118-5","volume":"73","author":"S Macalou","year":"2016","unstructured":"Macalou, S. et al. The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport. Cell. Mol. Life Sci. 73, 1927\u20131937 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"49_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3410\/B3-23","volume":"3","author":"A Basseville","year":"2011","unstructured":"Basseville, A. & Bates, S. E. Gout, genetics and ABC transporters. F1000 Biol. Rep. 3, 23 (2011).","journal-title":"F1000 Biol. Rep."},{"key":"49_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11095-008-9752-7","volume":"26","author":"T Furukawa","year":"2009","unstructured":"Furukawa, T. et al. Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations. Pharm. Res. 26, 469\u2013479 (2009).","journal-title":"Pharm. Res."},{"key":"49_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.108.138115","volume":"326","author":"Y Liu","year":"2008","unstructured":"Liu, Y., Yang, Y., Qi, J., Peng, H. & Zhang, J. T. Effect of cysteine mutagenesis on the function and disulfide bond formation of human ABCG2. J. Pharmacol. Exp. Ther. 326, 33\u201340 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"49_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/138920010792927325","volume":"11","author":"Z Ni","year":"2010","unstructured":"Ni, Z., Bikadi, Z., Rosenberg, M. F. & Mao, Q. Structure and function of the human breast cancer resistance protein (BCRP\/ABCG2). Curr. Drug Metab. 11, 603\u2013617 (2010).","journal-title":"Curr. Drug Metab."},{"key":"49_CR51","doi-asserted-by":"publisher","first-page":"22644","DOI":"10.1074\/jbc.M212399200","volume":"278","author":"M Suzuki","year":"2003","unstructured":"Suzuki, M., Suzuki, H., Sugimoto, Y. & Sugiyama, Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem. 278, 22644\u201322649 (2003).","journal-title":"J. Biol. Chem."},{"key":"49_CR52","first-page":"87","volume":"308","author":"S Geisse","year":"2005","unstructured":"Geisse, S., Jordan, M. & Wurm, F. M. Large-scale transient expression of therapeutic proteins in mammalian cells. Methods Mol. Biol. 308, 87\u201398 (2005).","journal-title":"Methods Mol. Biol."},{"key":"49_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0076-6879(09)64011-8","volume":"464","author":"TK Ritchie","year":"2009","unstructured":"Ritchie, T. K. et al. Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods Enzymol. 464, 211\u2013231 (2009).","journal-title":"Methods Enzymol."},{"key":"49_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nprot.2007.519","volume":"3","author":"ER Geertsma","year":"2008","unstructured":"Geertsma, E. R., Nik Mahmood, N. A., Schuurman-Wolters, G. K. & Poolman, B. Membrane reconstitution of ABC transporters and assays of translocator function. Nat. Protoc. 3, 256\u2013266 (2008).","journal-title":"Nat. Protoc."},{"key":"49_CR55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0003-2697(73)90217-0","volume":"56","author":"W Schaffner","year":"1973","unstructured":"Schaffner, W. & Weissmann, C. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56, 502\u2013514 (1973).","journal-title":"Anal. Biochem."},{"key":"49_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-2697(88)90002-4","volume":"168","author":"S Chifflet","year":"1988","unstructured":"Chifflet, S., Torriglia, A., Chiesa, R. & Tolosa, S. A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases. Anal. Biochem. 168, 1\u20134 (1988).","journal-title":"Anal. Biochem."},{"key":"49_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1093","volume":"1","author":"CJ Wienken","year":"2010","unstructured":"Wienken, C. J., Baaske, P., Rothbauer, U., Braun, D. & Duhr, S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat. Commun. 1, 100 (2010).","journal-title":"Nat. Commun."},{"key":"49_CR58","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"49_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"49_CR60","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18722","volume":"5","author":"D Kimanius","year":"2016","unstructured":"Kimanius, D., Forsberg, B. O., Scheres, S. H. & Lindahl, E. Accelerated cryo-EM structure determination with parallelisation using GPUs in RELION-2. eLife 5, e18722 (2016).","journal-title":"eLife"},{"key":"49_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"49_CR62","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jmb.2003.07.013","volume":"333","author":"PB Rosenthal","year":"2003","unstructured":"Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721\u2013745 (2003).","journal-title":"J. Mol. Biol."},{"key":"49_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nmeth.2727","volume":"11","author":"A Kucukelbir","year":"2014","unstructured":"Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63\u201365 (2014).","journal-title":"Nat. Methods"},{"key":"49_CR64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"49_CR65","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1107\/S0907444909029436","volume":"65","author":"NW Moriarty","year":"2009","unstructured":"Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D Biol. Crystallogr. 65, 1074\u20131080 (2009).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"49_CR66","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"49_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Nature Structural & Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41594-018-0049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41594-018-0049-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41594-018-0049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:22:23Z","timestamp":1684606943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41594-018-0049-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1038\/s41594-018-0049-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732973547.793569202","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732973547.793546442","asserted-by":"object"}]},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}